From costs to results and pain, our contributing beauty editor shares her experience of trying polynucleotides for the hands ...

The technique has been used to increase circulation and in some cases reduce fluid buildup. Whether it tightens and brightens ...

The FDA has approved a subcutaneous dose for initiation of lecanemab treatment in adults with Alzheimer’s disease, according ...

Long-term clinical data reveal that continuous systemic biologic therapy provides durable skin clearance and itch relief for ...

Since 1971, Travel + Leisure editors have followed one mission: to inform, inspire, and guide travelers to have deeper, more meaningful experiences. T+L's editors have traveled to countries all over ...

The most common side effects of IV lecanemab are headache, infusion-related reactions, and amyloid-related imaging abnormalities, a side effect known to occur with the class of an ...

A new under‑the‑skin version of isatuximab is now approved, giving multiple myeloma patients a much faster and more ...

The FDA has approved Leqembi Iqlik (lecanemab-irmb) subcutaneous weekly starting dose, enabling fully at-home treatment initiation for early Alzheimer disease.

Joseph Mikhael, MD, MEd, highlights the clinical and logistical advantages of the novel on-body injector developed for the ...